Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 16,281,000 $ 22,707,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 13,644,000 10,685,000
Costs recognized on sale of acquired inventory 4,219,000 1,113,000
Deferred income taxes (1,170,000) (1,115,000)
Stock-based compensation expense 3,176,000 2,038,000
Fair value adjustment to contingent consideration payable 1,900,000
Other 262,000 26,000
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables (10,176,000) (3,763,000)
Inventories (2,414,000) (3,176,000)
Prepaid expenses 605,000 (766,000)
Trade accounts payable and accrued expenses 4,132,000 (416,000)
Salaries, wages and related accruals (7,257,000) (1,704,000)
Income taxes payable 2,850,000 6,204,000
Net cash provided by operating activities 26,502,000 31,833,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisitions, net of cash acquired (259,004,000) (82,970,000)
Proceeds from available-for-sale investments 3,930,000
Purchases of available for sale investments (6,836,000)
Additions to property and equipment (2,442,000) (6,121,000)
Net cash used in investing activities (268,282,000) (85,161,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (11,932,000) (11,894,000)
Proceeds from stock option exercises 2,026,000 1,128,000
Excess tax benefit from stock option exercises 253,000 131,000
Borrowings under line-of-credit agreement 343,500,000 77,000,000
Payments on line-of-credit (91,513,000) (24,500,000)
Net cash provided by financing activities 242,334,000 41,865,000
Effect of exchange rate changes on cash and cash equivalents 5,248,000 5,773,000
Net increase (decrease) in cash and cash equivalents 5,352,000 (5,690,000)
Cash and cash equivalents at beginning of period 64,237,000 54,532,000
Cash and cash equivalents at end of period $ 69,589,000 $ 48,842,000